SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-070103
Filing Date
2023-12-13
Accepted
2023-12-13 17:14:53
Documents
14
Period of Report
2023-12-13
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 8-K srzn-20231213.htm   iXBRL 8-K 50553
2 EX-3.1 srzn-ex3_1.htm EX-3.1 16516
  Complete submission text file 0000950170-23-070103.txt   228837

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srzn-20231213_def.xml EX-101.DEF 14088
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srzn-20231213_lab.xml EX-101.LAB 18129
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srzn-20231213_pre.xml EX-101.PRE 13396
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srzn-20231213.xsd EX-101.SCH 3109
8 EXTRACTED XBRL INSTANCE DOCUMENT srzn-20231213_htm.xml XML 6766
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

IRS No.: 301374889 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39635 | Film No.: 231484901
SIC: 2836 Biological Products, (No Diagnostic Substances)